Treatment outcome in patients with HCV Genotype-3a Infection, Treated with 24-Weeks Dual Therapy (Sofosbuvir and Ribavirin). mfm [Internet]. 2024 May 19 [cited 2026 Feb. 1];28(11). Available from: https://medicalforummonthly.com/index.php/mfm/article/view/4275